These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 12879076

  • 21. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
    Zhang T, Ma J, Cao X.
    Biochem J; 2003 Dec 01; 376(Pt 2):457-64. PubMed ID: 14498832
    [Abstract] [Full Text] [Related]

  • 22. Integrin alphavbeta3 is a coreceptor for human cytomegalovirus.
    Wang X, Huang DY, Huong SM, Huang ES.
    Nat Med; 2005 May 01; 11(5):515-21. PubMed ID: 15834425
    [Abstract] [Full Text] [Related]

  • 23. Epidermal growth factor receptor is not required for human cytomegalovirus entry or signaling.
    Isaacson MK, Feire AL, Compton T.
    J Virol; 2007 Jun 01; 81(12):6241-7. PubMed ID: 17428848
    [Abstract] [Full Text] [Related]

  • 24. Human cytomegalovirus glycoprotein-receptor interactions.
    Rasmussen L, Resta S, Merigan T.
    Transplant Proc; 1991 Jun 01; 23(3 Suppl 3):60-3. PubMed ID: 1648838
    [Abstract] [Full Text] [Related]

  • 25. Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B.
    Simmen KA, Singh J, Luukkonen BG, Lopper M, Bittner A, Miller NE, Jackson MR, Compton T, Früh K.
    Proc Natl Acad Sci U S A; 2001 Jun 19; 98(13):7140-5. PubMed ID: 11390970
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Evidence for the role of cell protein phosphorylation in human cytomegalovirus/host cell fusion.
    Keay S, Baldwin BR.
    J Gen Virol; 1996 Oct 19; 77 ( Pt 10)():2597-604. PubMed ID: 8887496
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Blocking cellular N-glycosylation suppresses human cytomegalovirus entry in human fibroblasts.
    Zheng L, Li H, Fu L, Liu S, Yan Q, Leng SX.
    Microb Pathog; 2020 Jan 19; 138():103776. PubMed ID: 31600539
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Immunological methods for the detection of human cytomegalovirus.
    Yurochko AD, Huang ES.
    Methods Mol Med; 2000 Jan 19; 33():1-19. PubMed ID: 21340949
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Engineered receptors for human cytomegalovirus that are orthogonal to normal human biology.
    Park J, Gill KS, Aghajani AA, Heredia JD, Choi H, Oberstein A, Procko E.
    PLoS Pathog; 2020 Jun 19; 16(6):e1008647. PubMed ID: 32559251
    [Abstract] [Full Text] [Related]

  • 40. Update on the 92.5 kDa putative HCMV fusion receptor.
    Keay S, Baldwin B.
    Scand J Infect Dis Suppl; 1995 Jun 19; 99():32-3. PubMed ID: 8668940
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.